Grifols Reports Strong First Half 2025 Results with Robust Revenue Growth, Rising Profitability, and Strategic Progress Across Business Units Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and a world…
Labcorp Earns IVDR CE-Marking for PGDx elio™ tissue complete, Paving the Way for Expanded Personalized Oncology Testing Across Europe In a milestone achievement that advances the accessibility of precision oncology…
Novo Nordisk Ushers in New Era of Leadership as Maziar Mike Doustdar Is Named President and CEO, Effective August 7, 2025 Novo Nordisk, a global healthcare leader renowned for its…
DecisionRx and BeneCard PBF Unite to Transform Pharmacy Benefits Through Personalized Medication Optimization In a bold move poised to reshape how pharmacy benefits are delivered and experienced across the U.S.,…
AGC Biologics’ Heidelberg Facility to Manufacture Drug Substance for Phase II Trials of Valneva’s Four-Valent Shigella Vaccine Candidate AGC Biologics, a global contract development and manufacturing organization (CDMO), announced a…
IntraBio’s AQNEURSA® Gains CHMP Recommendation for Niemann-Pick Disease Type C, Signaling Major Breakthrough in Rare Neurological Disorder Treatment In a landmark development for the rare disease community, IntraBio Inc., a…
Avance Clinical Ushers in a New Era of Trial Excellence Through Strategic Digital Validation Partnership with ValGenesis In a strategic move set to redefine the landscape of clinical research quality…
Simulations Plus and Polish Academy Scientists Validate AI-Powered Drug Design Models in Breakthrough Discovery Targeting Inflammation and Immune Regulation Simulations Plus, Inc. (Nasdaq: SLP), a prominent developer of modeling and…
Compass Pathways Appoints Biopharmaceutical Veteran Justin Gover to Board of Directors as Company Advances Toward Potential Regulatory Milestone Compass Pathways plc (Nasdaq: CMPS), a biotechnology company at the forefront of…
Centauri Therapeutics Secures Additional $5.1M from CARB-X to Propel Lead Antibacterial Candidate ABX-01 Into First-in-Human Trials Centauri Therapeutics Limited, an innovative immunotherapy company leveraging a novel platform for combating infectious…
Bio-Rad Laboratories Appoints Rajat Mehta as Executive Vice President of Global Commercial Operations, Marking a New Era in Strategic Leadership Herculean succession marks leadership transition following the retirement of Mike…
BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Early-Stage Lung Cancer, Expanding Its Role in Perioperative NSCLC Treatment BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global…